LAHORE: The Punjab Directorate of Drugs Control has issued an official warning to withdraw certain medicines from the market. Manufacturers have been instructed to recall specific batches identified as substandard or adulterated.
The alert follows testing by the Drug Testing Laboratories Punjab, which classified these medicines as either adulterated or substandard. Consequently, the Provincial Quality Control Board directed the immediate removal of these products from circulation.
Medicines Subject to Recall:
- Injection Neudex 1mL (Dexamethasone sodium phosphate equivalent to Dexamethasone phosphate 4mg/mL)
- Registration Number: 042943
- Batch Nos: DX063, DX079 (Expiry: October 2027)
- Batch No: DX080 (Expiry: November 2027)
- The laboratory declared this injection as adulterated.
- Infusion Zeesol H 1000mL (Ringer Lactate)
- Contains: Calcium Chloride (0.27g), Potassium Chloride (0.40g), Sodium Chloride (6.00g), Sodium Lactate (3.20g), Water for Injection
- Batch No: 2503281 (Expiry: February 2030)
- This product was classified as substandard following sterility testing.
The Drugs Control authorities have ordered the manufacturers of these batches to retrieve the products from the market, provide a complete distribution record, and upload the “Recall Assessment Form” on the DRAP website at dra.gov.pk/publications/application-forms/Recall. Additionally, they are required to conduct a thorough root cause analysis and develop a Corrective and Preventive Action (CAPA) plan.
Healthcare providers, including pharmacies, medical stores, wholesalers, distributors, and medical facilities, are advised to cease dispensing these medicines immediately. They must also report their current stock levels and usage data to the relevant Drug Inspector or Distributor.
All field offices across Punjab have been directed to intensify surveillance of the supply chain and enforce regulatory measures in accordance with the Drug Act 1976 and DRAP regulations to ensure public safety.
